Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) HKSE

21.78

-0.38(-1.71%)

Updated at May 14 10:49AM

Currency In HKD

Valuation

Market Cap6.63B
Enterprise Value6.12B
P/E Ratio25.33
PEG Ratio0.17
Price/Sales Ratio5.84
Price/Book Ratio1.9
Enterprise/Revenue5.35
Enterprise/EBITDA26.23

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterDecember 31, 2025

Profitability

Profit Margin0.23
Operating Margin0.19

Management Effectiveness

Return On Assets0.07
Return On Equity0.08

Income Statement

Revenue1.03B
Revenue/Share3.28
Gross Profit743.17M
EBITDA195.07M
Net Income238.05M
Diluted EPS0.75

Balance Sheet

Total Cash1.73B
Total Cash/Share5.42
Total Debt63.67M
Total Debt/Equity0.02
Current Ratio5.98
Book Value Per Share10.11

Price History

52-Week Change14.82
52-Week High28
52-Week Low18.04
Moving Average 50 Days22.75
Moving Average 200 Days23.73

Statistics

Average Volume739,006
Shares Outstanding318.67M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.09
Trailing Annual Dividend Yield0.49
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A